Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Vivimed Labs Limited (NSE: VIVIMEDLAB), ISIN INE526G01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VIVIMEDLAB last traded at ₹5.45 (-1.27%), with a 52-week range of ₹4.75 to ₹29.40 (as of 6 Nov 2026).
Shareholding as of Mar 2026: promoters 7.57%, FIIs 1.64%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 3/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.